DOGWOOD THERAPEUTICS INC (DWTX) Stock Income Statement
USA - NASDAQ:DWTX - US92829J2033 - Common Stock
5.57 USD
+0.11 (+2.01%)
5.55 USD
-0.02 (-0.36%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 31.70M | 12.23M | 5.45M | 12.32M | 15.64M | |||
| Research and Development | 21.84M | 3.53M | 1.73M | 8.07M | 10.80M | |||
| Selling, General, and Administrative Expenses | 9.86M | 8.70M | 3.72M | 4.25M | 4.85M | |||
| Operating Income | -31.70M | -12.23M | -5.45M | -12.32M | -15.64M | |||
| Interest Income/Expense | -177.60K | -123.00K | 150.90K | 70.00K | -320.00K | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -38.02M | -12.35M | -5.30M | -12.25M | -15.96M | |||
| Income Tax | 188.70K | -500 | null | null | null | |||
| Net Income | -39.98M | -12.86M | -5.30M | -12.25M | -15.96M | |||
| EBITDA | null | -12.22M | undefined | undefined | undefined | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -24.9248 | -12.516 | -7.0513 | -1.11 | -1.92 | |||
| Non GAAP EPS | -20.25 | -10.92 | -7 | -32.75 | null | |||
| Statistics | ||||||||
All data in USD